PROPANC BIOPHARMA, INC. Debt Instrument, Convertible, Conversion Price
PROPANC BIOPHARMA, INC. (PPCB) had Debt Instrument, Convertible, Conversion Price of $225.00 per share as of 2025-03-05, per its S-1 filed 2026-07-17.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2026-07-17
- 2013-09-30: Debt Instrument, Convertible, Conversion Price 0.07 AUD.
AUD
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2013-09-30 | 0.07 AUD 10-Q · filed 2015-02-17 |
USD/shares
| Period end | Debt Instrument, Convertible, Conversion Price | Debt Instrument, Convertible, Conversion Price as first filed |
|---|---|---|
| 2025-03-05 | $225.00 S-1 · filed 2026-07-17 | $8.58 10-Q · filed 2025-05-15 |
| 2025-01-05 | $225.00 S-1 · filed 2026-07-17 | $9.00 10-K · filed 2025-09-29 |
| 2021-03-31 | $0.28 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $0.54 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-16 | |
| 2020-01-02 | $0.17 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $0.70 10-Q · filed 2019-11-14 | |
| 2019-07-02 | $0.47 10-Q · filed 2019-11-14 | |
| 2019-03-31 | $0.01 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $0.02 10-Q · filed 2019-05-15 | |
| 2018-09-30 | $0.01 10-Q · filed 2019-02-14 | |
| 2016-03-31 | $0.03 10-Q · filed 2016-05-16 | |
| 2015-06-04 | $0.07 10-Q · filed 2016-05-16 | |
| 2014-12-26 | $0.00 10-Q · filed 2015-02-17 | |
| 2014-12-16 | $0.00 10-Q · filed 2015-02-17 | |
| 2014-12-10 | $0.00 10-Q · filed 2015-02-17 | |
| 2014-12-09 | $0.00 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $0.01 10-Q · filed 2014-11-19 | |
| 2014-07-31 | $0.07 10-Q · filed 2015-02-17 | |
| 2014-07-02 | $0.07 10-K · filed 2015-09-30 | |
| 2013-09-30 | $0.07 10-Q · filed 2015-02-17 | $0.07 10-Q · filed 2014-11-19 |
AUD/shares
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2013-09-30 | 0.07 AUD/shares 10-Q · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |